1. Home
  2. DGICA vs FTRE Comparison

DGICA vs FTRE Comparison

Compare DGICA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGICA
  • FTRE
  • Stock Information
  • Founded
  • DGICA 1986
  • FTRE 1996
  • Country
  • DGICA United States
  • FTRE United States
  • Employees
  • DGICA N/A
  • FTRE N/A
  • Industry
  • DGICA Property-Casualty Insurers
  • FTRE Medical Specialities
  • Sector
  • DGICA Finance
  • FTRE Health Care
  • Exchange
  • DGICA Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • DGICA 683.3M
  • FTRE 701.9M
  • IPO Year
  • DGICA N/A
  • FTRE N/A
  • Fundamental
  • Price
  • DGICA $19.57
  • FTRE $10.12
  • Analyst Decision
  • DGICA Hold
  • FTRE Hold
  • Analyst Count
  • DGICA 1
  • FTRE 9
  • Target Price
  • DGICA $18.00
  • FTRE $12.06
  • AVG Volume (30 Days)
  • DGICA 151.4K
  • FTRE 1.9M
  • Earning Date
  • DGICA 10-23-2025
  • FTRE 11-07-2025
  • Dividend Yield
  • DGICA 3.73%
  • FTRE N/A
  • EPS Growth
  • DGICA 965.80
  • FTRE N/A
  • EPS
  • DGICA 2.34
  • FTRE N/A
  • Revenue
  • DGICA $993,644,532.00
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • DGICA $2.26
  • FTRE N/A
  • Revenue Next Year
  • DGICA $2.96
  • FTRE N/A
  • P/E Ratio
  • DGICA $8.36
  • FTRE N/A
  • Revenue Growth
  • DGICA 3.36
  • FTRE N/A
  • 52 Week Low
  • DGICA $14.06
  • FTRE $3.97
  • 52 Week High
  • DGICA $21.12
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • DGICA 67.13
  • FTRE 61.73
  • Support Level
  • DGICA $18.71
  • FTRE $9.42
  • Resistance Level
  • DGICA $19.74
  • FTRE $10.57
  • Average True Range (ATR)
  • DGICA 0.46
  • FTRE 0.65
  • MACD
  • DGICA 0.20
  • FTRE -0.06
  • Stochastic Oscillator
  • DGICA 94.24
  • FTRE 49.60

About DGICA Donegal Group Inc.

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: